Valuation OneSource Specialty Pharma Limited
Stocks
ONESOURCE
INE013P01021
Biotechnology & Medical Research
|
Market Closed -
NSE India S.E.
15:05:09 26/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,397.30 INR | +4.74% |
|
-0.75% | -22.83% |
| 10-23 | Dr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit | RE |
| 10-23 | Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption | RE |
Company Valuation: OneSource Specialty Pharma Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| Market Cap 1 | 200,521 | 168,871 | 160,234 | - | - |
| Change | - | -15.78% | -5.11% | - | - |
| Enterprise Value (EV) 1 | 200,521 | 180,604 | 169,090 | 161,398 | 160,234 |
| Change | - | -9.93% | -6.38% | -4.55% | -0.72% |
| P/E | -1,075x | -229x | 34.5x | 16.7x | - |
| PBR | - | - | 2.55x | 2.25x | 2.2x |
| PEG | - | -1x | -0x | 0x | - |
| Capitalization / Revenue | - | 11.9x | 7.35x | 4.71x | 5.38x |
| EV / Revenue | - | 12.7x | 7.76x | 4.74x | 5.38x |
| EV / EBITDA | - | 59.4x | 21.5x | 11.8x | 13.9x |
| EV / EBIT | - | 719x | 30.6x | 15.6x | 18.9x |
| EV / FCF | - | -32.2x | 30.6x | 21.5x | 20.7x |
| FCF Yield | - | -3.1% | 3.27% | 4.64% | 4.83% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -1.63 | -6.44 | 40.5 | 83.73 | - |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | 14,216 | 21,798 | 34,019 | 29,769 |
| EBITDA 1 | - | 3,042 | 7,875 | 13,689 | 11,544 |
| EBIT 1 | - | 251.3 | 5,526 | 10,322 | 8,472 |
| Net income 1 | -179.7 | -738 | 4,459 | 8,968 | 7,308 |
| Net Debt 1 | - | 11,733 | 8,856 | 1,164 | - |
| Reference price 2 | 1,752.25 | 1,473.30 | 1,397.30 | 1,397.30 | 1,397.30 |
| Nbr of stocks (in thousands) | 114,436 | 114,621 | 114,674 | - | - |
| Announcement Date | 05/05/25 | 13/05/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 32.94x | 7.42x | 20.55x | - | 1.61B | |
| 18.83x | 6.63x | 13.18x | 1.58% | 64.69B | |
| 30.16x | 8x | 26.2x | 0.05% | 54.78B | |
| 36.79x | 6.53x | 19.51x | 0.88% | 53.49B | |
| 35.59x | 3.45x | 14.87x | -.--% | 45.98B | |
| 49.71x | 5.74x | 31.52x | -.--% | 42.94B | |
| -19.41x | 187.75x | -20.66x | -.--% | 40.08B | |
| 28.93x | 8.21x | 21.27x | 0.37% | 33.52B | |
| 27.67x | 5.83x | 15.12x | -.--% | 23.97B | |
| 32.59x | 5.97x | 20.28x | -.--% | 23.67B | |
| Average | 27.38x | 24.55x | 16.18x | 0.32% | 38.47B | |
| Weighted average by Cap. | 26.74x | 25.25x | 15.93x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ONESOURCE Stock
- Valuation OneSource Specialty Pharma Limited
Select your edition
All financial news and data tailored to specific country editions
